Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinming Su

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Molecular Cancer Therapeutics|March 31, 2021
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C Fox, Xinming Su, Jennifer L Davis, et al.
Cancer Research|September 1, 2017
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer MetastasesMichael H Ross, Alison K Esser, Gregory C Fox, et al.
The Journal of Clinical Investigation|September 22, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodelingXinming Su, Desiree H Floyd, Alun Hughes, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
ERJ Open Research|June 18, 2026
Characteristics and management of asthma from the China Asthma Data Registry ProjectKefang Lai, Tingting Xu, Ping Chen, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Molecular Cancer Therapeutics|March 31, 2021
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C Fox, Xinming Su, Jennifer L Davis, et al.
Cancer Research|September 1, 2017
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer MetastasesMichael H Ross, Alison K Esser, Gregory C Fox, et al.
The Journal of Clinical Investigation|September 22, 2012
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodelingXinming Su, Desiree H Floyd, Alun Hughes, et al.
Cancer Discovery|March 8, 2023
p38MAPKα Stromal Reprogramming Sensitizes Metastatic Breast Cancer to ImmunotherapyDouglas V Faget, Xianmin Luo, Matthew J Inkman, et al.
ERJ Open Research|June 18, 2026
Characteristics and management of asthma from the China Asthma Data Registry ProjectKefang Lai, Tingting Xu, Ping Chen, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Pageof 7